Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00305786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors
ClinicalTrials.gov study NCT01678690. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma
ClinicalTrials.gov study NCT02172976. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT00697905. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT00209677. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer
ClinicalTrials.gov study NCT01396681. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer
ClinicalTrials.gov study NCT00270907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00071136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients
ClinicalTrials.gov study NCT06531447. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.
ClinicalTrials.gov study NCT05497778. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT03721744. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Gemcitabine + Docetaxel + Toripalimab Induction in Epstein-Barr Virus (EBV) Associated Nasopharyngeal Carcinoma(NPC)
ClinicalTrials.gov study NCT06592599. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer
ClinicalTrials.gov study NCT00966706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
ClinicalTrials.gov study NCT00410774. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer
ClinicalTrials.gov study NCT02155088. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma.
ClinicalTrials.gov study NCT04405622. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
ClinicalTrials.gov study NCT00625664. IPD Sharing: Not stated. Countries: 19. Publications: 0.
S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
ClinicalTrials.gov study NCT00055835. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors
ClinicalTrials.gov study NCT07046650. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT04164082. IPD Sharing: YES. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.